![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SDK1 |
Gene summary for SDK1 |
![]() |
Gene information | Species | Human | Gene symbol | SDK1 | Gene ID | 221935 |
Gene name | sidekick cell adhesion molecule 1 | |
Gene Alias | SDK1 | |
Cytomap | 7p22.2 | |
Gene Type | protein-coding | GO ID | GO:0001654 | UniProtAcc | Q7Z5N4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
221935 | SDK1 | CCI_2 | Human | Cervix | CC | 9.11e-18 | 1.45e+00 | 0.5249 |
221935 | SDK1 | CCI_3 | Human | Cervix | CC | 1.38e-34 | 1.44e+00 | 0.516 |
221935 | SDK1 | CCII_1 | Human | Cervix | CC | 1.31e-05 | 2.79e-01 | 0.3249 |
221935 | SDK1 | AEH-subject1 | Human | Endometrium | AEH | 5.12e-23 | 6.65e-01 | -0.3059 |
221935 | SDK1 | AEH-subject2 | Human | Endometrium | AEH | 1.01e-10 | 4.35e-01 | -0.2525 |
221935 | SDK1 | AEH-subject3 | Human | Endometrium | AEH | 3.41e-08 | 3.78e-01 | -0.2576 |
221935 | SDK1 | AEH-subject4 | Human | Endometrium | AEH | 3.50e-26 | 8.48e-01 | -0.2657 |
221935 | SDK1 | AEH-subject5 | Human | Endometrium | AEH | 1.74e-11 | 5.01e-01 | -0.2953 |
221935 | SDK1 | EEC-subject1 | Human | Endometrium | EEC | 2.33e-19 | 6.46e-01 | -0.2682 |
221935 | SDK1 | EEC-subject2 | Human | Endometrium | EEC | 5.61e-04 | 1.44e-01 | -0.2607 |
221935 | SDK1 | EEC-subject3 | Human | Endometrium | EEC | 8.89e-22 | 4.09e-01 | -0.2525 |
221935 | SDK1 | EEC-subject4 | Human | Endometrium | EEC | 8.02e-15 | 5.54e-01 | -0.2571 |
221935 | SDK1 | GSM5276934 | Human | Endometrium | EEC | 1.91e-10 | -2.23e-01 | -0.0913 |
221935 | SDK1 | GSM5276935 | Human | Endometrium | EEC | 3.50e-03 | -2.01e-01 | -0.123 |
221935 | SDK1 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 2.53e-08 | -2.29e-01 | -0.1869 |
221935 | SDK1 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 1.07e-10 | -2.45e-01 | -0.1875 |
221935 | SDK1 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 3.64e-12 | -2.70e-01 | -0.1883 |
221935 | SDK1 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 6.13e-08 | -8.30e-02 | -0.1934 |
221935 | SDK1 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 4.74e-16 | -2.58e-01 | -0.1917 |
221935 | SDK1 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 2.95e-16 | -2.70e-01 | -0.1916 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00343298 | Cervix | CC | cell junction assembly | 88/2311 | 420/18723 | 3.42e-07 | 1.38e-05 | 88 |
GO:00163587 | Cervix | CC | dendrite development | 58/2311 | 243/18723 | 4.52e-07 | 1.76e-05 | 58 |
GO:00609965 | Cervix | CC | dendritic spine development | 28/2311 | 99/18723 | 1.61e-05 | 3.15e-04 | 28 |
GO:00609984 | Cervix | CC | regulation of dendritic spine development | 18/2311 | 61/18723 | 2.84e-04 | 3.07e-03 | 18 |
GO:0150063 | Cervix | CC | visual system development | 63/2311 | 375/18723 | 6.58e-03 | 3.65e-02 | 63 |
GO:0001654 | Cervix | CC | eye development | 62/2311 | 371/18723 | 7.83e-03 | 4.13e-02 | 62 |
GO:0048880 | Cervix | CC | sensory system development | 63/2311 | 381/18723 | 9.29e-03 | 4.66e-02 | 63 |
GO:00343299 | Endometrium | AEH | cell junction assembly | 78/2100 | 420/18723 | 4.80e-06 | 1.24e-04 | 78 |
GO:00163588 | Endometrium | AEH | dendrite development | 46/2100 | 243/18723 | 2.56e-04 | 3.03e-03 | 46 |
GO:00508086 | Endometrium | AEH | synapse organization | 67/2100 | 426/18723 | 2.67e-03 | 1.94e-02 | 67 |
GO:003432914 | Endometrium | EEC | cell junction assembly | 79/2168 | 420/18723 | 8.37e-06 | 1.85e-04 | 79 |
GO:001635813 | Endometrium | EEC | dendrite development | 44/2168 | 243/18723 | 1.72e-03 | 1.34e-02 | 44 |
GO:005080812 | Endometrium | EEC | synapse organization | 68/2168 | 426/18723 | 3.73e-03 | 2.49e-02 | 68 |
GO:00343297 | Lung | IAC | cell junction assembly | 86/2061 | 420/18723 | 7.98e-09 | 1.10e-06 | 86 |
GO:00163586 | Lung | IAC | dendrite development | 55/2061 | 243/18723 | 1.35e-07 | 1.18e-05 | 55 |
GO:00609964 | Lung | IAC | dendritic spine development | 25/2061 | 99/18723 | 5.18e-05 | 1.18e-03 | 25 |
GO:00609983 | Lung | IAC | regulation of dendritic spine development | 16/2061 | 61/18723 | 7.09e-04 | 9.50e-03 | 16 |
GO:00508085 | Lung | IAC | synapse organization | 65/2061 | 426/18723 | 4.05e-03 | 3.31e-02 | 65 |
GO:003432912 | Lung | AIS | cell junction assembly | 84/1849 | 420/18723 | 2.16e-10 | 5.71e-08 | 84 |
GO:001635812 | Lung | AIS | dendrite development | 49/1849 | 243/18723 | 9.53e-07 | 6.69e-05 | 49 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SDK1 | SNV | Missense_Mutation | novel | c.4442N>T | p.Arg1481Ile | p.R1481I | Q7Z5N4 | protein_coding | tolerated(0.12) | possibly_damaging(0.882) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
SDK1 | SNV | Missense_Mutation | c.4976N>T | p.Ser1659Leu | p.S1659L | Q7Z5N4 | protein_coding | tolerated(1) | benign(0) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR | |
SDK1 | SNV | Missense_Mutation | novel | c.5728N>A | p.Leu1910Met | p.L1910M | Q7Z5N4 | protein_coding | tolerated(0.18) | possibly_damaging(0.83) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
SDK1 | SNV | Missense_Mutation | novel | c.827N>C | p.Phe276Ser | p.F276S | Q7Z5N4 | protein_coding | tolerated(0.4) | benign(0.009) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SDK1 | SNV | Missense_Mutation | novel | c.4604N>T | p.Ala1535Val | p.A1535V | Q7Z5N4 | protein_coding | tolerated(0.35) | benign(0.015) | TCGA-AJ-A3NE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SDK1 | SNV | Missense_Mutation | rs753019500 | c.5012N>A | p.Arg1671Gln | p.R1671Q | Q7Z5N4 | protein_coding | tolerated(0.05) | benign(0.069) | TCGA-AJ-A8CT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SDK1 | SNV | Missense_Mutation | rs764015744 | c.3031N>A | p.Val1011Met | p.V1011M | Q7Z5N4 | protein_coding | tolerated(0.18) | probably_damaging(0.975) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SDK1 | SNV | Missense_Mutation | c.3372N>T | p.Glu1124Asp | p.E1124D | Q7Z5N4 | protein_coding | tolerated(0.53) | benign(0.329) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SDK1 | SNV | Missense_Mutation | c.2495N>C | p.Val832Ala | p.V832A | Q7Z5N4 | protein_coding | deleterious(0.02) | possibly_damaging(0.601) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
SDK1 | SNV | Missense_Mutation | rs532281867 | c.3077N>T | p.Thr1026Met | p.T1026M | Q7Z5N4 | protein_coding | tolerated(0.12) | probably_damaging(0.94) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |